SuRo Capital Valuation
Is SSSS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Earnings vs. similares
Price-To-Earnings vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of SSSS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: Datos insuficientes para calcular el valor razonable de SSSS para el análisis de valoración.
Muy por debajo del valor justo: Datos insuficientes para calcular el valor razonable de SSSS para el análisis de valoración.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SSSS?
Other financial metrics that can be useful for relative valuation.
| What is SSSS's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$103.44m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 22.6x |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does SSSS's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 21.6x | ||
HGBL Heritage Global | 7.8x | 9.3% | US$95.9m |
WHG Westwood Holdings Group | 11.4x | n/a | US$108.4m |
TCOA Zalatoris Acquisition | 38.1x | n/a | US$116.3m |
IXAQ IX Acquisition | 29.2x | n/a | US$117.5m |
SSSS SuRo Capital | 20.3x | n/a | US$103.4m |
Price-To-Earnings vs. similares: SSSS es un buen valor basado en su Ratio Price-To-Earnings (21.2x) comparado con la media de sus homólogos (21.5x).
Price to Earnings Ratio vs Industry
How does SSSS's PE Ratio compare vs other companies in the US Capital Markets Industry?
Price-To-Earnings vs. Industria: SSSS es un buen valor basado en su Ratio Price-To-Earnings (20.4x) comparado con la media del sector US Capital Markets (20.7x).
Price to Earnings Ratio vs Fair Ratio
What is SSSS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 20.3x |
| Fair PE Ratio | n/a |
PM vs. Ratio Justo: Datos insuficientes para calcular SSSS's Price-To-Earnings Fair Ratio para el análisis de valoración.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$4.05 | US$6.69 +65.1% | 27.1% | US$9.75 | US$5.00 | n/a | 4 |
| Mar ’25 | US$4.30 | US$6.56 +52.6% | 28.6% | US$9.75 | US$5.00 | n/a | 4 |
| Feb ’25 | US$3.73 | US$6.56 +75.9% | 28.6% | US$9.75 | US$5.00 | n/a | 4 |
| Jan ’25 | US$3.94 | US$6.56 +66.6% | 28.6% | US$9.75 | US$5.00 | n/a | 4 |
| Dec ’24 | US$4.00 | US$6.56 +64.1% | 28.6% | US$9.75 | US$5.00 | n/a | 4 |
| Nov ’24 | US$4.20 | US$6.38 +51.8% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Oct ’24 | US$3.62 | US$6.38 +76.1% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Sep ’24 | US$3.61 | US$6.38 +76.6% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Aug ’24 | US$4.06 | US$6.38 +57.0% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Jul ’24 | US$3.20 | US$6.38 +99.5% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Jun ’24 | US$3.30 | US$6.38 +93.2% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| May ’24 | US$3.65 | US$6.38 +74.7% | 24.4% | US$9.00 | US$5.00 | n/a | 4 |
| Apr ’24 | US$3.62 | US$7.00 +93.4% | 25.4% | US$9.50 | US$5.50 | US$4.42 | 3 |
| Mar ’24 | US$3.64 | US$7.33 +101.5% | 21.1% | US$9.50 | US$6.00 | US$4.30 | 3 |
| Feb ’24 | US$4.01 | US$7.33 +82.9% | 21.1% | US$9.50 | US$6.00 | US$3.73 | 3 |
| Jan ’24 | US$3.80 | US$7.75 +103.9% | 19.6% | US$9.50 | US$6.00 | US$3.94 | 4 |
| Dec ’23 | US$4.07 | US$7.75 +90.4% | 19.6% | US$9.50 | US$6.00 | US$4.00 | 4 |
| Nov ’23 | US$4.09 | US$9.50 +132.3% | 24.1% | US$12.00 | US$6.00 | US$4.20 | 4 |
| Oct ’23 | US$3.87 | US$10.25 +164.9% | 12.7% | US$12.00 | US$9.00 | US$3.62 | 4 |
| Sep ’23 | US$6.34 | US$10.25 +61.7% | 12.7% | US$12.00 | US$9.00 | US$3.61 | 4 |
| Aug ’23 | US$6.62 | US$13.63 +105.8% | 13.1% | US$16.00 | US$11.00 | US$4.06 | 4 |
| Jul ’23 | US$6.48 | US$13.63 +110.3% | 13.1% | US$16.00 | US$11.00 | US$3.20 | 4 |
| Jun ’23 | US$7.48 | US$13.63 +82.2% | 13.1% | US$16.00 | US$11.00 | US$3.30 | 4 |
| May ’23 | US$8.18 | US$14.38 +75.7% | 6.7% | US$16.00 | US$13.50 | US$3.65 | 4 |
| Apr ’23 | US$8.64 | US$14.38 +66.4% | 6.7% | US$16.00 | US$13.50 | US$3.62 | 4 |
Pronóstico de los analistas: El precio objetivo es más de un 20% superior al precio actual de la acción, pero los analistas no están de acuerdo en un rango estadísticamente seguro.